Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

482
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

174
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Topical Tranexamic Acid versus Phenylephrine-lidocaine for the Treatment of Anterior Epistaxis in Patients Taking Aspirin or Clopidogrel; a Randomized Clinical Trial

Pages

  0-0

Abstract

 Introduction: Epistaxis is one of the most prevalent complaints in the emergency department (ED), especially in patients who take antiplatelet agents. This study aimed to compare the effect of topical use of Tranexamic Acid (TXA) with phenylephrine-lidocaine anterior nasal packing (PANP) in controlling Epistaxis of patients who take Aspirin or Clopidogrel. Methods: This prospective, double-blind, parallel-group, randomized clinical trial was conducted to compare the effect of topical use of intravenous (IV) TXA compared with PANP on controlling anterior Epistaxis in patients who take Aspirin or Clopidogrel. Results: One hundred patients with the mean age of 59. 24 § 7. 75 (45 – 75) years were studied (52%male). Two groups were similar in terms of age (p=0. 81) and sex (p=0. 23) distribution, diabetes mellitus (p=0. 54), and hypertension (p = 0. 037). The mean time to stop bleeding was 6. 70 § 2. 35 minutes in the TXA group and 11. 50§ 3. 64 minutes in the PANP group (p=0. 002). Bleeding recurrence occurred in 3 (6%) cases of the TXA group and 10 (20%) cases of the PANP group (p =0. 03). Time to discharge from ED in the TXA group was significantly lower than the PANP group (p<0. 001). The absolute risk reduction (ARR), relative risk reduction, and number needed to harm of treatment with TXA for anterior nasal bleeding were 14. 00% (95%CI: 1. 11 – 26. 89), 17. 50% (95%CI: 0. 60-37. 27), and 7. 14 (95%CI: 3. 71-90. 43), respectively. Conclusion: Topical TXA is an appropriate treatment option in bleeding cessation, and reducing re-bleeding and duration of hospital stay in patients with Epistaxis who take antiplatelet agents.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    AMINI, KEYVAN, Arabzadeh, Amir Ahmad, Jahed, Sevda, & Amini, Payman. (2021). Topical Tranexamic Acid versus Phenylephrine-lidocaine for the Treatment of Anterior Epistaxis in Patients Taking Aspirin or Clopidogrel; a Randomized Clinical Trial. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY), 9(1), 0-0. SID. https://sid.ir/paper/768878/en

    Vancouver: Copy

    AMINI KEYVAN, Arabzadeh Amir Ahmad, Jahed Sevda, Amini Payman. Topical Tranexamic Acid versus Phenylephrine-lidocaine for the Treatment of Anterior Epistaxis in Patients Taking Aspirin or Clopidogrel; a Randomized Clinical Trial. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY)[Internet]. 2021;9(1):0-0. Available from: https://sid.ir/paper/768878/en

    IEEE: Copy

    KEYVAN AMINI, Amir Ahmad Arabzadeh, Sevda Jahed, and Payman Amini, “Topical Tranexamic Acid versus Phenylephrine-lidocaine for the Treatment of Anterior Epistaxis in Patients Taking Aspirin or Clopidogrel; a Randomized Clinical Trial,” ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY), vol. 9, no. 1, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/768878/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top